We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
4d Pharma Plc | LSE:DDDD | London | Ordinary Share | GB00BJL5BR07 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.36 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDDDD TIDMAV.
RNS Number : 4509J
4d Pharma PLC
09 September 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ----------------------------------------------------------------------------------------------------- 1. Identity of the issuer or 4D Pharma plc the underlying issuer of existing shares to which voting rights are attached: (ii) --------------------------------------------------------------- ------------------------------------ 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights --------------------------------------------------------------------- ------------------------------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached --------------------------------------------------------------------- ------------------------------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments --------------------------------------------------------------------- ------------------------------ An event changing the breakdown of voting rights --------------------------------------------------------------------- ------------------------------ Other (please specify): ----------------------------------------------------------- -------- ------------------------------ 3. Full name of person(s) Aviva plc & its subsidiaries subject to the notification obligation: (iii) ------------------------------------------------------------- -------------------------------------- 4. Full name of shareholder(s) Registered Holder: (if different from 3.):(iv) BNY Norwich Union Nominees Limited 143,637* Chase (GA Group) Nominees Limited 2,096,957* * denotes direct interest Chase (GA Group) Nominees Limited 175,084 Chase Nominees Limited 83,372 Vidacos Nominees Limited 118,418 ------------------------------------------------------------- -------------------------------------- 5. Date of the transaction 06 July 2016 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------------- -------------------------------------- 6. Date on which issuer notified: 07 July 2016 ------------------------------------------------------------- -------------------------------------- 7. Threshold(s) that is/are 5% to <5% Change at Combined crossed or Interest Level (Box 8A & 8B) reached: (vi, vii) ------------------------------------------------------------- -------------------------------------- 8. Notified details: -------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) -------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------------ ------------------------------- --------------------------------------------------------- Number Number Number Number of % of voting of of of voting rights (x) Shares Voting shares rights Rights ------------------ ------------------ ----------- ------------ ---------------------- ------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------------ ------------------ ----------- ------------ ---------- ---------- ------- ---------- Ordinary Shares GB00BJL5BR07 ------------ ---------- ---------- 3,276,932* 3,276,932* 2,617,468 2,240,594 376,874 3.46% 0.58% ------------------ ------------------ ----------- ------------ ---------- ---------- ------- ---------- * Includes Right to Recall Loaned Shares (350,800) -------------------------------------------------------------------------------------------------------------- B: Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion rights that rights (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ------------------ ------------------ ------------------------- ---------------------- ------------------- 617,754* RIGHT TO RECALL LOANED SHARES N/A N/A * Direct Interest 0.95% ------------------ ------------------ ------------------------- ---------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights (xix, (xvii) period refers to xx) (xviii) ------------------ --------- ----------- ------------ ------------------- ---------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 3,235,222 4.99% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------- The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Proxy Voting: --------------------------------------------------------------- 10. Name of the proxy holder: See Section 4 -------------------------------------------- ----------------- 11. Number of voting rights proxy holder will cease to hold: -------------------------------------------- ----------------- 12. Date on which proxy holder will cease to hold voting rights: -------------------------------------------- ----------------- 13. Additional information: Figures are based on the total number of voting rights of 64,858,150 as per the Company's 'Acquisition' announcement of 8 April 2016. ------------------------------- ---------------------------------
14. Contact name: Neil Whittaker, Aviva plc ------------------------------- --------------------------------- 15. Contact telephone number: 01603 684420 ------------------------------- ---------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFEIAVIAIIR
(END) Dow Jones Newswires
September 09, 2016 06:58 ET (10:58 GMT)
1 Year 4d Pharma Chart |
1 Month 4d Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions